| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |